High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS)

Overview

Journal Glob Heart

Publisher Ubiquity Press

Specialty Cardiology & Vascular Diseases

Date 2020 Jun 4

PMID 32489776

Citations 19

Authors

Pooya Koosha

Hamidreza Roohafza

Nizal Sarrafzadegan

Mehrbod Vakhshoori

Mohammad Talaei

Erfan Sheikhbahaei

Masoumeh Sadeghi

Affiliations

Soon will be listed here.

Abstract

Background: High sensitivity C-reactive protein (hs-CRP) was proven to be an independent risk factor for cardiovascular diseases (CVDs). The aim of this study was to investigate the benefits of assessing hs-CRP among individuals with different cardiovascular risk factors.

Methods: This nested case-control study was obtained from the Isfahan Cohort Study (ICS). Anyone who has been suffering from any CVDs, including myocardial infarction, unstable angina, sudden cardiac death and stroke was put in the case group. Density sampling method was utilized to choose the control group who had no aforementioned CVDs during follow-up. Four quartiles of hs-CRP (Q1: 0.1-2.3, Q2: 2.4-3, Q3: 3.1-4 and Q4: 4.1-14 mg/l) were assessed defining odds ratios (OR) of CVDs prediction in different CVDs risk factor categories. Confidence intervals of 95% are put in brackets.

Results: A total of 502 cases and 538 controls were recruited. All hs-CRP quartiles showed increased CVDs likelihood compared to normal subjects in terms of diabetes mellitus (DM) and hypertension (HTN). Second quartile showed a 1.93 [1.33-2.81] and 3.34 [1.36-8.17] increased risks in patients with hypertriglyceridemia or dyslipidemia, respectively. Smokers in the third quartile group revealed increased CVDs risk. The fourth quartile showed significant increased risks in patients suffering from hypercholesterolemia (OR = 1.91 [1.33-2.74]), high LDL-C (OR = 1.88 [1.33-2.66]), and hypertriglyceridemia (OR = 2.31 [1.57-3.41]).

Conclusions: Our findings suggested that assessing hs-CRP is beneficial for predicting CVDs in patients with HTN and DM. Furthermore, specific patients with lipid abnormalities or history of smoking benefits from checking hs-CRP.

Citing Articles

The predictive role of the hs-CRP/HDL-C ratio for long-term mortality in the general population: evidence from a cohort study.

Wang Y, Wang L, Zhao Z, Yin S, Tang X, Zhang K BMC Cardiovasc Disord. 2024; 24(1):758.

PMID: 39736563 PMC: 11684128. DOI: 10.1186/s12872-024-04446-1.

Association between coexisting hypertension, dyslipidaemia and elevated C reactive protein with cardiovascular disease and mortality: a cross-sectional and longitudinal analysis in a representative cohort of older US adults.

Karadimas T, Meier H BMJ Public Health. 2024; 2(2).

PMID: 39583776 PMC: 11580688. DOI: 10.1136/bmjph-2023-000455.

A linear positive association between high-sensitivity C-reactive protein and the prevalence of cardiovascular disease among individuals with diabetes.

Liu Y, He W, Ji Y, Wang Q, Li X BMC Cardiovasc Disord. 2024; 24(1):411.

PMID: 39118024 PMC: 11308650. DOI: 10.1186/s12872-024-04091-8.

Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study.

Waritu N, Nair S, Usure R, Jemal M Front Med (Lausanne). 2024; 11:1370725.

PMID: 39086939 PMC: 11288884. DOI: 10.3389/fmed.2024.1370725.

The impact of platelet-to-lymphocyte ratio on clinical outcomes in heart failure: a systematic review and meta-analysis.

Vakhshoori M, Bondariyan N, Sabouhi S, Kiani K, Alaei Faradonbeh N, Emami S Ther Adv Cardiovasc Dis. 2024; 18:17539447241227287.

PMID: 38305256 PMC: 10838041. DOI: 10.1177/17539447241227287.

References

Wang C, Yatsuya H, Tamakoshi K, Uemura M, Li Y, Wada K . Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up. Diabetes Metab Res Rev. 2013; 29(5):398-405. DOI: 10.1002/dmrr.2406. View

Kazemi-Saleh D, Koosha P, Sadeghi M, Sarrafzadegan N, Karbasi-Afshar R, Boshtam M . Predictive role of adiponectin and high-sensitivity C-reactive protein for prediction of cardiovascular event in an Iranian cohort Study: The Isfahan Cohort Study. ARYA Atheroscler. 2016; 12(3):132-137. PMC: 5055371. View

Lee J, Yang D, Park H, Cho Y, Lee W, Chun B . Incremental predictive value of high-sensitivity C-reactive protein for incident hypertension: the Hypertension-Diabetes Daegu Initiative study. Clin Exp Hypertens. 2013; 36(5):302-8. DOI: 10.3109/10641963.2013.810236. View

Lin C, Kardia S, Li C, Liu C, Lai M, Lin W . The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health. 2010; 10:579. PMC: 2956725. DOI: 10.1186/1471-2458-10-579. View

Xue H, Wang J, Hou J, Zhu H, Gao J, Chen S . Association of ideal cardiovascular metrics and serum high-sensitivity C-reactive protein in hypertensive population. PLoS One. 2013; 8(12):e81597. PMC: 3862853. DOI: 10.1371/journal.pone.0081597. View

Ding D, Wang M, Su D, Hong C, Li X, Yang Y . Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease. PLoS One. 2015; 10(8):e0135713. PMC: 4539189. DOI: 10.1371/journal.pone.0135713. View

Rubinstein A, Irazola V, Poggio R, Bazzano L, Calandrelli M, Zanetti F . Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: the CESCAS I study. BMJ Open. 2011; 1(1):e000126. PMC: 3191438. DOI: 10.1136/bmjopen-2011-000126. View

Wang X, Du Y, Fan L, Ye P, Yuan Y, Lu X . Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS One. 2013; 8(12):e81778. PMC: 3849294. DOI: 10.1371/journal.pone.0081778. View

Whelton S, Roy P, Astor B, Zhang L, Hoogeveen R, Ballantyne C . Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013; 178(7):1076-84. PMC: 3783092. DOI: 10.1093/aje/kwt086. View

10.

Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, Bahonar A . The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study. Adv Biomed Res. 2014; 3:242. PMC: 4260292. DOI: 10.4103/2277-9175.145749. View

11.

Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Aparna A, Pavithran P . Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk. Clin Exp Hypertens. 2008; 30(5):367-74. DOI: 10.1080/10641960802275106. View

12.

Kianoush S, Bittencourt M, Lotufo P, Bensenor I, Jones S, DeFilippis A . Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Am Heart Assoc. 2017; 6(8). PMC: 5586473. DOI: 10.1161/JAHA.117.006545. View

13.

Zaghloul A, Al-Bukhari T, Al-Pakistani H, Shalaby M, Halawani S, Bajuaifer N . Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications. Diabetes Res Clin Pract. 2014; 106(3):597-604. DOI: 10.1016/j.diabres.2014.09.007. View

14.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

15.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2005; 21(1):1-6. DOI: 10.1097/01.hco.0000200416.65370.a0. View

16.

Bilhorn K, Luo Y, Lee B, Wong N . High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults. Am J Cardiol. 2012; 110(10):1464-7. DOI: 10.1016/j.amjcard.2012.06.056. View

17.

Ebrahimi M, Heidari-Bakavoli A, Shoeibi S, Mirhafez S, Moohebati M, Esmaily H . Association of Serum hs-CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors. J Clin Lab Anal. 2016; 30(5):672-6. PMC: 6807047. DOI: 10.1002/jcla.21920. View

18.

Khaledi Y, Aghababaei E, Sadeghi M, Hashemi M, Sanei H . Evaluation of heart rate reserve and high-sensitivity C-reactive protein in individuals with and without metabolic syndrome in Isfahan, Iran. ARYA Atheroscler. 2012; 8(2):70-5. PMC: 3463992. View

19.

Alaei Faradonbeh N, Nikaeen F, Akbari M, Almasi N, Vakhshoori M . Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein. ARYA Atheroscler. 2019; 14(4):163-168. PMC: 6312566. DOI: 10.22122/arya.v14i4.1685. View

20.

Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View